Microbiota Manipulation as a Metagenomic Therapeutic Approach for Rare Inherited Metabolic Disorders

Clin Pharmacol Ther. 2019 Sep;106(3):505-507. doi: 10.1002/cpt.1503. Epub 2019 Jul 4.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 4-Aminobutyrate Transaminase / deficiency
  • Amino Acid Metabolism, Inborn Errors / physiopathology
  • Amino Acid Metabolism, Inborn Errors / therapy
  • Animals
  • Developmental Disabilities / physiopathology
  • Developmental Disabilities / therapy
  • Fecal Microbiota Transplantation / methods
  • Gastrointestinal Microbiome / physiology*
  • Humans
  • Metabolism, Inborn Errors / physiopathology*
  • Metabolism, Inborn Errors / therapy
  • Mice
  • Prebiotics / administration & dosage
  • Probiotics / administration & dosage
  • RNA, Ribosomal, 16S / metabolism
  • Rare Diseases / physiopathology*
  • Rare Diseases / therapy
  • Severity of Illness Index
  • Succinate-Semialdehyde Dehydrogenase / deficiency

Substances

  • Prebiotics
  • RNA, Ribosomal, 16S
  • Succinate-Semialdehyde Dehydrogenase
  • 4-Aminobutyrate Transaminase

Supplementary concepts

  • Gamma aminobutyric acid transaminase deficiency
  • succinic semialdehyde dehydrogenase deficiency